Lactobacillus group and arterial hypertension: A broad review on effects and proposed mechanisms.

Autor: de Assis Gadelha DD; Health Sciences Center, Federal University of Paraíba, João Pessoa, PB, Brazil., de Brito Alves JL; Health Sciences Center, Federal University of Paraíba, João Pessoa, PB, Brazil., da Costa PCT; Health Sciences Center, Federal University of Paraíba, João Pessoa, PB, Brazil., da Luz MS; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., de Oliveira Cavalcanti C; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., Bezerril FF; Technology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., Almeida JF; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., de Campos Cruz J; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., Magnani M; Technology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., Balarini CM; Health Sciences Center, Federal University of Paraíba, João Pessoa, PB, Brazil., Rodrigues Mascarenhas S; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., de Andrade Braga V; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil., de França-Falcão MDS; Biotechnology Center, Federal University of Paraíba, João Pessoa, PB, Brazil.
Jazyk: angličtina
Zdroj: Critical reviews in food science and nutrition [Crit Rev Food Sci Nutr] 2024; Vol. 64 (12), pp. 3839-3860. Date of Electronic Publication: 2022 Oct 21.
DOI: 10.1080/10408398.2022.2136618
Abstrakt: Hypertension is the leading risk factor for cardiovascular diseases and is associated with intestinal dysbiosis with a decrease in beneficial microbiota. Probiotics can positively modulate the impaired microbiota and impart benefits to the cardiovascular system. Among them, the emended Lactobacillus has stood out as a microorganism capable of reducing blood pressure, being the target of several studies focused on managing hypertension. This review aimed to present the potential of Lactobacillus as an antihypertensive non-pharmacological strategy. We will address preclinical and clinical studies that support this proposal and the mechanisms of action by which these microorganisms reduce blood pressure or prevent its elevation.
Databáze: MEDLINE